Improving Neuroprotective Strategy for Ischemic Stroke With Sufficient Recanalization After Thrombectomy by Edaravone Dexborneol
Clinical trial NCT04667637 · COMPLETED
Trial details
- NCT number
- NCT04667637
- Sponsor
- Hui-Sheng Chen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-23
- Primary completion
- 2022-10-10
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.